Zobrazeno 1 - 10
of 41
pro vyhledávání: '"M. M. Konopleva"'
Publikováno v:
Chemistry of Natural Compounds. 15:420-423
The herb low cudweed has yielded for the first time a new acylated flavone glycoside, for which the structure of 3′,4′,5,7-tetrahydroxy-6-methoxyflavone 7-O-(6″-O-caffeyl-β-D-glucopyranoside) has been established. In addition, 6-methoxyluteoli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c012ef2e8e06cfb12ac041a5a1f6b81
https://doi.org/10.1007/bf00565037
https://doi.org/10.1007/bf00565037
Publikováno v:
Chemistry of Natural Compounds. 15:269-272
A new acylated flavone glycoside has been isolated for the first time from the herb marsh cudweed, and for it the structure of 6″-caffeyl-7-β-D-glucopyranosyloxy-4′,5-dihydroxy-3′,6′dimethoxyflavone has been established. In addition, the agl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::726097f020b8d03cabb2116522c5a7d3
https://doi.org/10.1007/bf00566072
https://doi.org/10.1007/bf00566072
Publikováno v:
Chemistry of Natural Compounds. 14:339-340
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7baaa0a3bcdf34a0f6dbd1b4c8483917
https://doi.org/10.1007/bf00713339
https://doi.org/10.1007/bf00713339
Autor:
Konopleva M; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Milella M; Division of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy., Ruvolo P; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Watts JC; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Ricciardi MR; Hematology, Department of Biotecnologie Cellulari ed Ematologia, Sapienza, University of Rome, Rome, Italy., Korchin B; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Teresa M; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Bornmann W; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Tsao T; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Bergamo P; Division of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy., Mak DH; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Chen W; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., McCubrey J; Department of Microbiology & Immunology, Brody School of Medicine at East Carolina University, Greenville, NC, USA., Tafuri A; Hematology, Department of Biotecnologie Cellulari ed Ematologia, Sapienza, University of Rome, Rome, Italy., Andreeff M; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. mandreef@mdanderson.org.
Publikováno v:
Leukemia [Leukemia] 2024 Sep; Vol. 38 (9), pp. 2072.
Autor:
DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Tiong IS; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Quaglieri A; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology and., MacRaild S; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Brown FC; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Thijssen R; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology and., Pomilio G; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Ivey A; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia., Salmon JM; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Glytsou C; Department of Pathology and Perlmutter Cancer Center, NYU School of Medicine, New York, NY., Fleming SA; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Zhang Q; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ma H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Patel KP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Xu Z; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology and., Chua CC; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Chen X; Department of Pathology and Perlmutter Cancer Center, NYU School of Medicine, New York, NY., Blombery P; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; and.; Department of Haematology, The Royal Melbourne Hospital, Melbourne, VIC, Australia., Flensburg C; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology and., Cummings N; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia., Aifantis I; Department of Pathology and Perlmutter Cancer Center, NYU School of Medicine, New York, NY., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Huang DCS; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology and., Roberts AW; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology and.; Department of Haematology, The Royal Melbourne Hospital, Melbourne, VIC, Australia., Majewski IJ; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology and., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Wei AH; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
Publikováno v:
Blood [Blood] 2020 Mar 12; Vol. 135 (11), pp. 791-803.
Autor:
Boddu P; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jorgensen J; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia T; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alvarado Y; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bose P; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Naqvi K; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yilmaz M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pierce S; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Brandt M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour EJ; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cortes J; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia [Leukemia] 2018 Jan; Vol. 32 (1), pp. 241-244. Date of Electronic Publication: 2017 Sep 18.
Autor:
Boddu P; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Takahashi K; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Benton CB; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Pierce S; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Cortes J; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia [Leukemia] 2017 Nov; Vol. 31 (11), pp. 2526-2529. Date of Electronic Publication: 2017 Jul 28.
Autor:
Schito L; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Rey S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Oncogene [Oncogene] 2017 Sep 21; Vol. 36 (38), pp. 5331-5340. Date of Electronic Publication: 2017 May 22.
Autor:
Montalban-Bravo G, Huang X, Naqvi K, Jabbour E, Borthakur G, DiNardo CD, Pemmaraju N, Cortes J, Verstovsek S, Kadia T, Daver N, Wierda W, Alvarado Y, Konopleva M, Ravandi F, Estrov Z, Jain N, Alfonso A, Brandt M, Sneed T, Chen HC, Yang H, Bueso-Ramos C, Pierce S, Estey E, Bohannan Z, Kantarjian HM, Garcia-Manero G
Publikováno v:
Leukemia [Leukemia] 2017 Jul; Vol. 31 (7), pp. 1659. Date of Electronic Publication: 2017 Mar 24.
Autor:
Daver N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Estey E; Division of Hematology, University of Washington School of Medicine, Seattle, WA, USA., Wang X; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., O'Brien S; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Verstovsek S; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia T; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dinardo C; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pierce S; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang X; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Diaz-Pines-Mateo M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cortes J; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia [Leukemia] 2016 Feb; Vol. 30 (2), pp. 268-73. Date of Electronic Publication: 2015 Sep 14.